Ritah Namusoosa

Ritah Namusoosa


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2024 in Journal of Global Health
Verified
Journal Article
Open access
RNRitah Namusoosa
Ritah Namusoosa
IMIbrahimm Mugerwa
Ibrahimm Mugerwa
Keneth Iceland KasoziKeneth Iceland Kasozi
Keneth Iceland Kasozi
AMAllan Muruta
Allan Muruta
GNGrace Najjuka
Grace Najjuka
AMAdrian Muwonge
Adrian Muwonge
Antibiotic resistance (ABR) is a phenomenon where bacteria become unresponsive to antibiotics, and globally, it is estimated to cause 1.27 million deaths [1]. This disproportionately affects people living in sub-Saharan Africa, where 27.3 deaths per 100 000 population lose their lives due to hard-to-treat infections [2]. Vulnerable populations, including neonates, infants, and pregnant mothers, bear the […]

8 April 2025 in medRxiv
Verified
Preprint
Open access
PDF file
HKHannington Katumba
Hannington Katumba
Richard MigishaRichard Migisha
Richard Migisha
CMCharity Mutesi
Charity Mutesi
EMEmmanuel Mfitundinda
Emmanuel Mfitundinda
JNJoanita Nalwanga
Joanita Nalwanga
AAAlex Riolexus Ario
Alex Riolexus Ario
Background On March 7, 2024 the Ministry of Health (MoH) was notified of a rising number of inmates with suspected conjunctivitis in Luzira prisons in Uganda. We investigated this outbreak to determine its cause and extent, identify risk factors and recommend evidence-based control measures. Methods We investigated the outbreak in four prisons: Kampala Remand Prison (KRP), Murchison Bay Prison (MBP), Luzira Upper Prison (LUP) and Luzira Women Prison (LWP). A suspected case was onset of redness in one or both eyes with ≥1 of tearing, discharge, grainy sensation, itching, pain, or swelling, in any Luzira Prison resident from February 1 to April 3, 2024. We identified cases using medical records, and active case search among prisoners. We administered structured questionnaires and collected conjunctival swabs for PCR testing. We assessed movement of prisoners, handwashing, isolation practices, and administration of eye medications. We compared exposures of 200 randomly-selected cases 200 controls for the case control study. Using logistic regression, we conducted multivariable analysis to identify risk factors. Results We recorded 1,935 cases; overall attack rate was 23% (1,935/8,518), varying by prison: MBP (41%; 1,229/3,000), KRP (33%; 610/1,835), LUP (12%; 83/670), and LWP (0.4%; 13/3,013). With no associated deaths, most cases resolved within 4-5 days. Of the 10 samples tested, 4 (40%) were positive for Enterovirus Type C. Sharing of eye medication (aOR: 5.3, 95%CI: 2.8-9.9), and non-frequent handwashing increased odds of infection (aOR: 5.8, CI: 3.5-9.6). Prisoner mixing took place during a plea-bargain session amidst the outbreak. Symptomatic case-persons were isolated for 3 days. Conclusions The outbreak was caused by Enterovirus Type C, facilitated by prisoner mixing, sharing eye medications, short isolation periods, and inadequate hand hygiene practices. Improving infection prevention and control measures, including strict isolation, individualized eye medication, and enhanced hand hygiene practices, could prevent future outbreaks in similar settings.

16 December 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
ASAloysious Ssemaganda
Aloysious Ssemaganda
AAAlisen Ayitewala
Alisen Ayitewala
SKStephen Kanyerezi
Stephen Kanyerezi
HOHellen Rosette Oundo
Hellen Rosette Oundo
Julius SseruyangeJulius Sseruyange
Julius Sseruyange
ISIsaac Ssewanyana
Isaac Ssewanyana
Genomic technologies are transforming infectious disease surveillance and control, particularly in resource-limited settings such as Uganda. This review examines ongoing efforts by the Department of National Health Laboratory and Diagnostic Services - Central Public Health Laboratories (NHLDS-CPHL) to integrate genomics into public health strategies. We highlight key advancements, lessons learned, and opportunities, including expanded genomic testing capacity, localized bioinformatics infrastructure, and reinforcement of surveillance systems. Through use-case studies on COVID-19, HIV/AIDS, malaria, Ebola, Mpox, rotavirus, and cholera, we demonstrate the impact of genomics on improving diagnostic accuracy, disease monitoring and outbreak response, identifying drug resistance, and informing targeted public health interventions. Despite these successes, challenges, including but not limited to infrastructure gaps, funding constraints, and ethical considerations, remain, underscoring the need for policy, regulation, and capacity enhancement as well as global collaboration to effectively address these obstacles. Lessons learned from these efforts provide valuable recommendations for optimizing and sustaining genomic programs in low-resource settings. By leveraging genomics, Uganda can further strengthen its ability to detect, monitor, and respond to emerging and re-emerging health threats, ultimately enhancing disease control measures and public health resilience.